July 21–23, 2021 | Virtual
Extracellular vesicle studies
From benchtop to therapeutics
Extracellular vesicle studies: From benchtop to therapeutics
July 21–23, 2021 | Virtual
Extracellular vesicles are secreted, membrane-bound compartments containing DNA and cytoplasmic constituent molecules of all types that are thought to act as mediators of intercellular communication. They are classified by both size and location/mechanism of cellular origination. They are thought to be produced by an ever-expanding diversity of cell types and species. However, there is also considerable skepticism related to their existence and utility, as it can be difficult to isolate EVs since there is no EV-specific molecular marker to target.
A primary focus in recent years has been to describe the mechanisms of molecular sorting that would allow researchers to target proteins produced from exogenously introduced DNA to EVs for cellular secretion and uptake. The potential value of EVs to therapeutics is thought to be enormous, thanks to the role of EVs in cell–cell communication as a robust, native delivery vehicle.
This event will appeal to a broad audience, including molecular biologists, biochemists, biophysicists, secretion experts, cell–cell communication specialists, clinicians, physiologists and others.
Important dates
| July 16 11:59 p.m. Eastern |
Registration deadline |
|---|
Sponsors
Organizers
Speakers
Virtual event
Precious cargo?
In this Q&A, one of the meeting organizers urges the BMB community to interrogate the potential of enigmatic extracellular vesicles
Program schedule
All times listed are U.S. Eastern Daylight Time (GMT-4)
Wednesday agenda
Poster presentations
Keynote speaker
Virus-like biogenesis of extracellular vesicles
Jason Shephard, University of Utah School of Medicine
Vendor demos
Plenary session 1: Starting from scratch
Plenary session 2: Back to basics
Panel discussion: Individual EV uniqueness and ramifications
Poster presentations
Thursday agenda
Poster presentations
Keynote speaker
Jennifer Jones, National Institutes of Health
Vendor demos
Plenary session 3: Sources of EVs: opportunities and challenges (part 1)
Plenary session 4: Sources of EVs: opportunities and challenges (part 2)
Panel discussion: How to best control for a human EV experiment: methods, markers and analysis
Poster presentations
Friday agenda
Poster presentations
Keynote speaker
Joy Wolfram, Mayo Clinic Nanomedicine and Extracellular Vesicles Laboratory
Vendor demos
Plenary session 5: Special delivery
Plenary session 6: Carrying precious cargoes
Panel discussion: Needs of the field and future directions
Poster presentations
Sign up for email updates
Enter your email address below to receive updates about Extracellular vesicle studies